Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

New therapeutic agents for psychological disorders disclosed

April 19, 2006

New evidence that the ERK-Kv4.2 signaling pathway represents a target for pain

April 19, 2006

Phase I study finds intraputaminal CERE-120 feasible in Parkinson's disease

April 19, 2006

Glypromate completes phase II study in CABG patients

April 18, 2006

Combination treatment studied for relapsing remitting MS

April 18, 2006

New preclinical and clinical data presented on talampanel in seizures

April 18, 2006

Recent patents describe novel agents for neurological disorders

April 13, 2006

Novel analgesic agents reported in recent patents

April 13, 2006

Enrollment ahead of schedule in phase III study of VP-4896 for Alzheimer's

April 13, 2006

MBP-8298 delays multiple sclerosis progression

April 13, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...